High levels of the lncRNA ARHGAP5-AS1 induce m6A modification of ARHGAP5 mRNA by recruiting METTL3, which upregulates ARHGAP5 and induces chemo-resistance that is related to poor prognosis in GC patients [69]. Here, METTL3 is linked to gastric cancer.